Companies Dominating the Drug Screening Landscape
- Quest Diagnostics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Laboratory Corporation of America Holdings (LabCorp)
- Thermo Fisher Scientific
- Alere Inc.
- Siemens Healthineers
- Shimadzu Corporation
- F. Hoffmann-La Roche AG
- Express Diagnostics International Inc.
- OraSure Technologies
- Drägerwerk AG & Co. KGaA
Browse Key Market Insights with Data Illustration:
In the News
- Quest Diagnostics: Quest Diagnostics announced that it had received emergency use authorization from the U.S. Food and Drug Administration (FDA) for a new test that can detect the Omicron variant of the COVID-19 virus. The test is called the "Quest SARS-CoV-2 RT-PCR test for the detection of the Omicron variant" and is designed to be used with respiratory specimens.
- Thermo Fisher Scientific: Thermo Fisher Scientific announced that it had completed the acquisition of PPD, a leading global contract research organization (CRO). The acquisition will expand Thermo Fisher's capabilities in clinical research services and strengthen its position in the healthcare and life sciences markets. The acquisition was valued at USD 27.2 billion and is one of the largest in the history of the healthcare industry.